{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T10:03:38Z","timestamp":1785578618714,"version":"3.56.0"},"reference-count":15,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T00:00:00Z","timestamp":1232409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:p>Recent news reports have linked the human papillomavirus (HPV) vaccine to serious adverse events (AEs) in children and adolescents. We used the Vaccine Adverse Event Reporting System (VAERS) database to extract postmarketing AEs reported in patients who received the vaccine. Since approval of the HPV vaccine in the US, 3174 AEs occurring in children and adolescents (aged 6-17 y) have been reported to the VAERS. Of these, 191 (6%) were deemed to be serious. Although these AEs are of significant concern, more research is required before they can be directly correlated with the vaccine.<\/jats:p>","DOI":"10.1345\/aph.1l492","type":"journal-article","created":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T20:59:08Z","timestamp":1232485148000},"page":"356-359","source":"Crossref","is-referenced-by-count":8,"title":["Human Papillomavirus Vaccine Safety in Pediatric Patients: An Evaluation of the Vaccine Adverse Event Reporting System"],"prefix":"10.1177","volume":"43","author":[{"given":"Nancy L","family":"Borja-Hart","sequence":"first","affiliation":[{"name":"College of Pharmacy, Nova Southeastern University, Ft. Lauderdale, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Benavides","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Nova Southeastern University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"Christensen","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Nova Southeastern University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2009,1,20]]},"reference":[{"key":"bibr1-aph.1L492","unstructured":"Quadrivalent human papillomavirus vaccine: recommendation of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2007;56:1\u201324."},{"key":"bibr2-aph.1L492","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.8.813"},{"key":"bibr3-aph.1L492","unstructured":"American Academy of Pediatrics. Prevention of human papillomavirus infection: provisional recommendations for immunization of females with quadrivalent human papillomavirus vaccine. www.cispimmunize.org\/ill\/pdf\/HPVprovisional.pdf (accessed 2008 Jul 24)."},{"key":"bibr4-aph.1L492","unstructured":"CNN: Health news. Complaints cause cervical cancer vaccine scrutiny. www.cnn.com\/health (accessed 2008 Jul 7)."},{"key":"bibr5-aph.1L492","unstructured":"WestenJH. Deaths associated with the HPV vaccine start rolling in, over 3500 adverse events reported. September 20, 2007. www.lifesitenews.com\/Idn\/2007\/sep\/07092004.hml (accessed 2008 Jul 25)."},{"key":"bibr6-aph.1L492","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061760"},{"key":"bibr7-aph.1L492","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061741"},{"key":"bibr8-aph.1L492","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-0461"},{"key":"bibr9-aph.1L492","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000253970.29190.5a"},{"key":"bibr10-aph.1L492","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70101-7"},{"key":"bibr11-aph.1L492","unstructured":"VAERS: Vaccine Adverse Event Reporting System. vaers.hhs.gov (accessed 2008 Jul 24)."},{"key":"bibr12-aph.1L492","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200404000-00002"},{"key":"bibr13-aph.1L492","unstructured":"WONDERCDC. Centers for Disease Control and Prevention. wonder.cdc.gov (accessed 2008 Jul 9)."},{"key":"bibr14-aph.1L492","unstructured":"Update: Guillain-Barr\u00e9 syndrome among recipients of Menactra meningococcal conjugate vaccine\u2014United States, June 2005\u2013September 2006. MMWR Morb Mortal Wkly Rep 2006;55:1120\u20134."},{"key":"bibr15-aph.1L492","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200102223440804"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1L492","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1L492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:06:18Z","timestamp":1777374378000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1345\/aph.1L492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,20]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1345\/aph.1L492"],"URL":"https:\/\/doi.org\/10.1345\/aph.1l492","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,20]]}}}